Canada markets open in 4 hours 53 minutes

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7000-0.0900 (-1.88%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
2,595
2,595
2,513
2,076
-
Cost of Revenue
-
857
805
422
-
Gross Profit
-
1,738
1,708
1,654
-
Operating Expenses
Research Development
89,929
93,730
117,363
205,319
32,527
Selling General and Administrative
58,892
64,986
57,218
31,366
5,985
Total Operating Expenses
148,821
158,716
174,581
236,685
38,512
Operating Income or Loss
-147,083
-156,978
-172,873
-235,031
-38,512
Interest Expense
2,253
2,328
1,538
-
-
Total Other Income/Expenses Net
11,559
3,411
7,211
5,506
-1,179
Income Before Tax
-135,901
-152,710
-165,662
-229,525
-39,691
Income Tax Expense
691
-731
-2,240
970
53
Income from Continuing Operations
-136,592
-151,979
-163,422
-230,495
-39,744
Net Income
-136,592
-151,979
-163,422
-230,495
-39,744
Net Income available to common shareholders
-136,592
-151,979
-163,422
-230,495
-39,744
Basic EPS
-
-1.53
-1.75
-10.22
-4.48
Diluted EPS
-
-1.53
-1.75
-10.22
-4.48
Basic Average Shares
-
99,446
93,240
22,559
8,873
Diluted Average Shares
-
99,446
93,240
22,559
8,873
EBITDA
-
-148,378
-171,198
-233,832
-38,210